SEC industry · SIC 2834
The SEC classifies these issuers under “Pharmaceutical Preparations” (SIC 2834). A shared code is a starting point for finding comparable businesses. Product mix, geography and customers can still differ substantially. Read the company descriptions before treating the group as direct competitors.
This group has 2 disclosed fiscal year-end dates. Align the reporting periods before comparing annual results. The calendar below shows each company’s year end separately from its filing date.
SEC data snapshot: . The linked reports are the annual filings stored in that snapshot; newer filings may exist. This is a coverage directory, not a complete industry census or a ranking of investments. Multiple share classes of one issuer count as one company.
Abbott operates across medical devices, diagnostics, nutrition, and established pharmaceuticals. Its continuous glucose-monitoring franchise has become a significant growth engine within medical devices.
AbbVie is a biopharmaceutical company known for immunology drugs, aesthetics, and neuroscience treatments. It has worked to replace revenue from its Humira franchise with newer immunology therapies.
Eli Lilly is a pharmaceutical company whose GLP-1 diabetes and obesity treatments have become blockbuster franchises. It also develops therapies in oncology, immunology, and neuroscience.
Johnson & Johnson develops prescription pharmaceuticals and medical devices following the spin-off of its consumer-health business. Its diversified drug and device pipeline supports a long record of dividend increases.
Merck is a research-driven pharmaceutical company whose Keytruda immunotherapy is one of the world's top-selling cancer drugs. It also maintains major vaccine and animal-health businesses.
Pfizer is a global pharmaceutical company with a broad portfolio spanning vaccines, oncology, and internal medicine. After its pandemic-era surge, it has leaned on acquisitions to rebuild its long-term pipeline.
Regeneron develops biologic medicines including the eye treatment Eylea and the immunology drug Dupixent.
Vertex Pharmaceuticals develops therapies for cystic fibrosis and other serious diseases including gene-based treatments.
Viatris makes generic and branded medicines distributed across global markets.
Zoetis develops medicines and vaccines for livestock and companion animals.
Compare AbbVie Inc. and Abbott Laboratories: business context, fiscal calendars and official filings.
Compare AbbVie Inc. and Johnson & Johnson: business context, fiscal calendars and official filings.
Compare AbbVie Inc. and Eli Lilly and Company: business context, fiscal calendars and official filings.
Compare AbbVie Inc. and Merck & Co., Inc.: business context, fiscal calendars and official filings.
Compare AbbVie Inc. and Pfizer Inc.: business context, fiscal calendars and official filings.
Compare AbbVie Inc. and Regeneron Pharmaceuticals, Inc.: business context, fiscal calendars and official filings.
Industry codes and annual filing references come from the SEC submissions snapshot linked to each issuer in our company catalog. Only groups with at least three distinct issuers, business descriptions and annual filing links are included.
SEC Standard Industrial Classification code list explains the classification system. Read our research methodology or browse all industry directories.
This page is company context and filings. Members get one sourced monthly call, a weekly evidence check, and the breakpoint written in advance. $15/month or $150/year.
$15/mo or $150/yr · cancel future renewals anytime · sources included